Critical Path Institute Board of Directors Announces President’s Plans to Retire

Posted on Mon/21/FebruaryWed/23/January by AZBio

C-Path founder Raymond L. Woosley, MD, PhD announces retirement plans.

ASU forms innovative international health care partnership

Posted on Thu/17/FebruaryWed/23/January by AZBio

Agreement establishes 1st Biosignatures Center between ASU and Taiwan’s Chang Gung University – partnership will improve patient outcomes and reduce costs.Continue reading→

Arizona companies team up, providing quick development of cancer drugs

Posted on Wed/26/JanuaryWed/23/January by AZBio

TGen Drug Development (TD2) and Flagship Biosciences offer combined oncology and pathology services for pharmaceutical and biotech clients.Continue reading→

Flagship Biosciences announces dermatopathology services for pharma clinical trials

Posted on Mon/17/JanuaryWed/23/January by AZBio

Flagship teams with Angela Wyatt Dermatology to offer dermatopathology clinical trials and discovery services to pharma and biotech firms.Continue reading→

Pathology delivered digitally in animal health product development

Posted on Tue/11/JanuaryWed/23/January by AZBio

Animal Health Consulting and Flagship Biosciences team to offer virtual pathology in animal health product development.Continue reading→

Gore Receives FDA Approval for Innovative GORE® C3 Delivery System for GORE® EXCLUDER® AAA Endoprosthesis

Posted on Tue/4/JanuaryWed/23/January by AZBio

New Innovation Enables Physicians and Interventionalists to Reposition Device for Ideal Placement in Treating Abdominal Aortic AneurysmsContinue reading→

2010 News

Posted on Sat/1/JanuaryWed/23/January by AZBio

AZBIO and AZBio Member News in 2010Continue reading→